Safety Related Label Changes for New Drugs After Approval in the US Through Expedited Regulatory Pathways: Retrospective Cohort Study

British Medical Journal - United Kingdom
doi 10.1136/bmj.j3837
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Breakthrough Therapy Status €“ Expedited FDA Regulatory Approval but What About the Payers?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Registration, Results Reporting, and Publication Bias of Clinical Trials Supporting FDA Approval of Neuropsychiatric Drugs Before and After FDAAA: A Retrospective Cohort Study

Trials
MedicinePharmacology
2018English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

Requirements for US Regulatory Approval of the International Thermonuclear Experimental Reactor (ITER)

1993English

Php357 - Making Sense From Anti-Sense: Lessons in Translating Expedited Regulatory Approval Into Reimbursement and Commercial Success

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Off Label Prescribing to Children in Primary Care in Germany: Retrospective Cohort Study

BMJ
2002English

Incidence of Skeletal-Related Events in Patients With Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US

Prostate Cancer
Cancer ResearchOncologyUrology
2019English

Identification of Approval Conditions for Orphan Drugs for Neurological Disorders by the Japanese Regulatory Agency

Expert Opinion on Orphan Drugs
ToxicologyPharmaceuticsPharmacologyHealth Policy
2018English

The Fetal Safety of Clomiphene Citrate: A Population-Based Retrospective Cohort Study

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy